Company / Operating Income per Share
Amneal Pharmaceuticals, Inc. Operating Income per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$2.24
FY2025
5-year range
-$1.88 / $2.24
FY2021-FY2025
Trend
+35.5%
vs FY2024
Sector context
#27 of 201
Health Care
What the data says
Amneal Pharmaceuticals, Inc.'s operating income per share of $2.24 is higher than 87% of companies in the Health Care sector (FY2025). Operating Income per Share has increased for 4 consecutive years, from $-1.88 in FY2021 to $2.24 in FY2025.
Based on SEC 10-K filings.
2.24 in FY2025. Top quartile in the Health Care sector.
Improved from $1.01 to $2.24 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
+107.8% above sector average
Key checks
Key Insights
- Amneal Pharmaceuticals, Inc.'s operating income per share has grown for 4 consecutive years.
- In FY2025, operating income per share increased 35.5% year-over-year.
- Ranks #27 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.24 | +35.5% |
| FY2024 | $1.65 | +64.2% |
| FY2023 | $1.01 | +257.8% |
| FY2022 | -$0.64 | +66.1% |
| FY2021 | -$1.88 | -1117.6% |
| FY2020 | -$0.15 | -108.0% |
| FY2019 | $1.93 | -14.0% |
| FY2018 | $2.24 | -100.0% |
| FY2017 | $245103.00 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026